Plasma derived polyvalent and hyperimmune immunoglobulin therapies are used to treat medical conditions including immune system deficiencies and bacterial or viral infections.
Binding Site understands that the testing requirements of the plasma protein therapeutics industry may be very different to those of clinical laboratories. Assays with higher measuring ranges have been developed for donor unit screening for specific IgG relevant to the manufacture of some hyperimmune globulins.
Plasma Donor Unit Screening
Plasma Donor Unit Screening| Description | Pack | Code |
|
VaccZyme™ Tetanus toxoid IgG kit |
10 x 96 test | MK010.4 |
| SPAplus Tetanus toxoid Latex IgG kit Range 1.56 - 50 IU/mL |
5 x 200 test | LK710.S |
For determining immune status and assessment of a patient's ability to respond to vaccination Binding Site also supplies VaccZyme™ Tetanus toxoid kits with lower measuring ranges.
Antisera and conjugated antisera to human immunoglobulins, immunoglobulin subclasses, coagulation factors, complement proteins and other serum proteins
MININEPH™, a small, single-sample, bench top nephelometer providing rapid quantification of serum proteins including immunogloblins, IgG subclasses and acute phase proteins.
Radial immunodiffusion assays for the quantification of complement proteins, IgG subclasses, acute phase proteins and other serum proteins.
